Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases

被引:180
作者
Malik, Hassan Z. [1 ]
Prasad, K. Rajendra [1 ]
Halazun, Karim J. [1 ]
Aldoori, Amir [1 ]
Al-Mukhtar, Ahmed [1 ]
Gomez, Dhanwant [1 ]
Lodge, J. Peter A. [1 ]
Toogood, Giles J. [1 ]
机构
[1] St James Univ Hosp, HPB & Transplant Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
10.1097/SLA.0b013e318142d964
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Despite indications for resection of colorectal liver metastases having expanded, debate continues about identifying patients that may benefit from surgery. Methods: Clinicopathologic data from a total of 700 patients was gathered between January 1993 and January 2006 from a prospectively maintained dataset. Of these, 687 patients underwent resection for colorectal liver metastases. Results: The median age of patient was 64 years and 36.8% of patients had synchronous disease. The overall 5-year survival was 45%. The presence of an inflammatory response to tumor (IRT), defined by an elevated C-reactive protein (>10 mg/L) or a neutrophil/lymphocyte ratio of >5:1, was noted in 24.5% of cases. Only the number of metastases and the presence or absence of an IRT influenced both overall and disease-free survival on multivariable analysis. A preoperative prognostic score was derived: 0 = less than 8 metastases and absence of IRT; 1 = 8 or more metastases or IRT, and 2 = 8 or more metastases and IRT - from the results of the multivariable analysis. The 5-year survival of those scoring 0 was 49% compared with 34% for those scoring 1. None of the patients that scored 2 were alive at 5 years. Conclusion: The preoperative prognostic score is a simple and effective system allowing preoperative stratification.
引用
收藏
页码:806 / 814
页数:9
相关论文
共 65 条
[1]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[2]   Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases? [J].
Adam, R ;
Pascal, G ;
Castaing, D ;
Azoulay, D ;
Delvart, V ;
Paule, B ;
Levi, F ;
Bismuth, H .
ANNALS OF SURGERY, 2004, 240 (06) :1052-1064
[3]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[4]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[5]   Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection [J].
Belghiti, J ;
Hiramatsu, K ;
Benoist, S ;
Massault, PP ;
Sauvanet, A ;
Farges, O .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) :38-46
[6]   Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy [J].
Bismuth, H ;
Adam, R ;
Levi, F ;
Farabos, C ;
Waechter, F ;
Castaing, D ;
Majno, P ;
Engerran, L .
ANNALS OF SURGERY, 1996, 224 (04) :509-520
[7]   Liver resection for colorectal metastases [J].
Bramhall, SR ;
Gur, U ;
Coldham, C ;
Gunson, BK ;
Mayer, AD ;
McMaster, P ;
Candinas, D ;
Buckels, JAC ;
Mirza, DF .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2003, 85 (05) :334-339
[8]   The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer [J].
Canna, K ;
McArdle, PA ;
McMillan, DC ;
McNicol, AM ;
Smith, GW ;
McKee, RF ;
McArdle, CS .
BRITISH JOURNAL OF CANCER, 2005, 92 (04) :651-654
[9]   Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases [J].
Chalmers, C. R. ;
Wilson, D. J. ;
Ward, J. ;
Robinson, P. J. ;
Toogood, G. J. ;
Hull, M. A. .
GUT, 2006, 55 (07) :1058-1059
[10]  
Chen Li, 2004, Hepatobiliary Pancreat Dis Int, V3, P530